Study Conduct

Big Data in clinical trials: Promise and pitfalls

Monday, August 15, 2016

Privacy versus medical progress. Proprietary ownership versus public information. Cost-effectiveness versus unnecessary burdens. Welcome to the swirl of opinions and emotions around Big Data and its potential—or not—in the clinical trials industry.

[Read More]

BTC Network rebrands, acquires Novex Clinical Research

Tuesday, August 2, 2016

BTC Network, a fully integrated network of clinical research sites in the U.S., has strengthened its site operations with the recent acquisition of Novex Clinical Research, a multi-specialty research practice in New Bedford, Massachusetts. As a result of the deal, Novex Clinical Research will be the first clinical research site to be owned and operated under the BTC Network umbrella. It will strengthen BTC Network’s expertise and commitment to therapeutic areas such as psychiatry, neurology, pain, and internal medicine.

[Read More]

Bioclinica expands U.S. study sites with Compass Research acquisition

Monday, August 1, 2016

Mergers and acquisitions continue in the CRO industry as companies aim to provide comprehensive trial support services alongside expansive participant recruitment networks. Bioclinica has acquired Compass Research, marking the company’s first foray into the U.S. investigational site network. Financial details of the acquisition were not released.
“By joining Bioclinica, Compass Research will become part of a global organization focused on bringing clarity to clinical trials,” said Elizabeth Thiele, president of Global Clinical Research for Bioclinica. “This expansion into the U.S. allows us to offer our full line of services to an even broader population of customers.”

[Read More]

Enrollment strategies in the PMI Cohort Study will bolster diversity in clinical research industry-wide

Monday, July 25, 2016

The Precision Medicine Initiative (PMI) Cohort Program is an ambitious observational study backed by the National Institutes of Health (NIH) that seeks to enroll at least one million Americans by 2020. Because of its massive scale, the Cohort Program is often compared to the 1948 Framingham Heart Study. Yet a crucial differentiator is that the Cohort Program aims to recruit participants with diverse backgrounds and ethnicities to better understand the root cause of disease for all Americans.

[Read More]

Three Questions: Blake Liebeskind, Sunrise Medical Research

Monday, July 25, 2016

CWWeekly presents this feature as a spotlight on issues faced by executives in clinical research. This week, writer Karyn Korieth spoke with Blake Liebeskind, president of Sunrise Medical Research in Florida, a finalist for the Society for Clinical Research Sites’ 2015 Site Patient Recruitment Innovation Award (SPRIA), which recognizes sites that employ innovative patient recruitment strategies.

[Read More]